Zoekresultaten - 26 results
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
Adult Belgium Carcinoma, Squamous Cell Child Female Guideline Adherence HEALTH POLICY Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Humans Insurance, Health, Reimbursement ...
Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.
aeruginosa and 8 S. aureus bacteriophages, specific for prevalent P. aeruginosa and S. aureus strains in the Burn Centre of the Queen Astrid Military Hospital in Brussels, Belgium. This cocktail, consisting of ...
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models.
cervical cancer mortality trend analysis Abstract: OBJECTIVE: To correct cervical cancer mortality rates for death cause certification problems in Belgium and to describe the corrected trends (1954-1997) ...
The Magistral Phage.
society. The greatest hurdle to the introduction of phage therapy in Western medicine is the lack of an appropriate legal and regulatory framework. Belgium is now implementing a pragmatic phage therapy ...
Cost-DALY comparison of hip replacement care in 12 Belgian hospitals
treatment in Belgium, the complication rate and potential waste reduction, as estimated by the Organisation for Economic Cooperation and Development, we are not yet in a position to assess the efficiency of ...
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.
triage-negative women of 0.5% to 0.9%). For the interpretation of cervical cytology specimen, there is no quality control programme yet. In Belgium, an ISO15189 accreditation (including participation in external ...